Credit Suisse Ag Cytokinetics Inc Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Cytokinetics Inc stock. As of the latest transaction made, Credit Suisse Ag holds 111,280 shares of CYTK stock, worth $5.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

111,280

Previous 107,371 3.64%

Holding current value

$5.1 Million

Previous $8.96 Million 12.97%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$63.75 - $108.06 $249,198 - $422,406	3,909 Added 3.64%	111,280 $7.8 Million
Q4 2023 Feb 08, 2024	SELL	$26.88 - $83.49 $138,727 - $430,891	-5,161 Reduced 4.59%	107,371 $8.96 Million
Q3 2023 Nov 13, 2023	SELL	$29.46 - $36.61 $354,285 - $440,271	-12,026 Reduced 9.65%	112,532 $3.32 Million
Q2 2023 Aug 11, 2023	BUY	$32.62 - $40.75 $746,117 - $932,074	22,873 Added 22.49%	124,558 $4.06 Million
Q1 2023 May 10, 2023	BUY	$33.36 - $45.71 $112,523 - $154,179	3,373 Added 3.43%	101,685 $3.58 Million
Q4 2022 Feb 13, 2023	BUY	$35.77 - $51.11 $23,429 - $33,477	655 Added 0.67%	98,312 $4.5 Million
Q3 2022 Nov 10, 2022	BUY	$38.54 - $54.52 $160,133 - $226,530	4,155 Added 4.44%	97,657 $4.73 Million
Q2 2022 Aug 12, 2022	SELL	$33.93 - $48.92 $11,943 - $17,219	-352 Reduced 0.38%	93,502 $3.67 Million
Q1 2022 May 16, 2022	BUY	$29.74 - $46.0 $235,421 - $364,136	7,916 Added 9.21%	93,854 $3.46 Million
Q4 2021 Feb 14, 2022	SELL	$34.35 - $46.38 $22,155 - $29,915	-645 Reduced 0.74%	85,938 $3.92 Million
Q3 2021 Nov 12, 2021	SELL	$18.54 - $35.74 $203,643 - $392,568	-10,984 Reduced 11.26%	86,583 $3.1 Million
Q2 2021 Aug 16, 2021	SELL	$19.79 - $26.99 $475,771 - $648,866	-24,041 Reduced 19.77%	97,567 $1.93 Million
Q1 2021 May 14, 2021	SELL	$18.57 - $25.68 $1.25 Million - $1.72 Million	-67,152 Reduced 35.58%	121,608 $2.83 Million
Q4 2020 Feb 12, 2021	BUY	$15.26 - $28.61 $881,829 - $1.65 Million	57,787 Added 44.12%	188,760 $3.92 Million
Q3 2020 Nov 13, 2020	BUY	$20.58 - $28.96 $946,309 - $1.33 Million	45,982 Added 54.1%	130,973 $2.84 Million
Q2 2020 Aug 12, 2020	BUY	$11.15 - $24.64 $651,461 - $1.44 Million	58,427 Added 219.95%	84,991 $2 Million
Q1 2020 May 13, 2020	SELL	$8.75 - $16.3 $70,341 - $131,035	-8,039 Reduced 23.23%	26,564 $313,000
Q4 2019 Feb 12, 2020	SELL	$7.95 - $11.84 $210,595 - $313,641	-26,490 Reduced 43.36%	34,603 $368,000
Q3 2019 Nov 12, 2019	BUY	$10.82 - $14.25 $342,593 - $451,197	31,663 Added 107.59%	61,093 $695,000
Q2 2019 Aug 14, 2019	SELL	$7.95 - $11.25 $15,486 - $21,915	-1,948 Reduced 6.21%	29,430 $331,000
Q1 2019 May 14, 2019	BUY	$5.95 - $10.19 $46,707 - $79,991	7,850 Added 33.36%	31,378 $253,000
Q4 2018 Feb 13, 2019	BUY	$5.91 - $9.29 $34,218 - $53,789	5,790 Added 32.64%	23,528 $149,000
Q3 2018 Nov 13, 2018	SELL	$6.4 - $9.85 $85,804 - $132,058	-13,407 Reduced 43.05%	17,738 $175,000
Q2 2018 Aug 14, 2018	SELL	$6.9 - $9.9 $40,509 - $58,122	-5,871 Reduced 15.86%	31,145 $259,000
Q1 2018 May 15, 2018	BUY	$7.2 - $10.05 $35,186 - $49,114	4,887 Added 15.21%	37,016 $266,000
Q4 2017 Feb 14, 2018	SELL	$7.25 - $15.65 $159,362 - $344,002	-21,981 Reduced 40.62%	32,129 $262,000
Q3 2017 Nov 14, 2017	BUY	$12.0 - $15.0 $116,256 - $145,320	9,688 Added 21.81%	54,110 $784,000
Q2 2017 Aug 14, 2017	BUY	N/A	44,422	44,422 $537,000

Others Institutions Holding CYTK

# of Institutions

407

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.31B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account